Podcast Episodes
Back to SearchMPN highlights at ASH 2022: Novel agents, combinations & the role of immunotherapy
Episode 181
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 8 months ago
T-cell lymphoma highlights at ASH 2022: unmet needs, clinical trial updates & future outlooks
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 8 months ago
T-cell lymphoma highlights at ASH 2022: Unmet needs, clinical trial updates & future outlooks
Episode 180
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 8 months ago
The importance of CD47 in MDS and other targets of interest
CD47 is a cell surface protein which is overexpressed in several cancer cells and appears to play an important role in a variety of hematological mal…
3 years, 8 months ago
The importance of CD47 in MDS and other targets of interest
Episode 179
CD47 is a cell surface protein which is overexpressed in several cancer cells and appears to play an important role in a variety of hematological mal…
3 years, 8 months ago
CLL highlights at ASH 2022: clinical trial updates, novel BTK inhibitors & combination therapy
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 8 months ago
CLL highlights at ASH 2022: Clinical trial updates, novel BTK inhibitors & combination therapy
Episode 178
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 8 months ago
Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 9 months ago
Myeloma highlights at ASH 2022: Improving access to CAR-T therapy & future outlooks
Episode 177
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 9 months ago
Highlights in MDS at ASH 2022: treating lower-risk & higher-risk disease, trial updates, & more
The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…
3 years, 9 months ago